We offer a complete range of services for female health including well-woman exams, contraceptive counselling, hormone evaluation, menopausal treatment, infertility evaluations, STD testing, evaluation of abnormal pap smears, and gynecologic surgery. Dr. Huster is especially excited by two new surgical technologies which offer women less invasive options for common gynecologic situations. Our patients have the option of having these procedures performed in our office setting.
Essure is a minimally invasive, FDA approved procedure for female sterilization. With Essure there are no incisions, and therefore no scars! The vaginal procedure can be done without general anesthesia with none of the pain associated with laparoscopic ("belly-button") surgery. Small sterile devices are placed into the fallopian tubes which then permanently occlude the tubes. The patient goes home with little or no discomfort and is back to normal activities the next day, This is a permanent procedure and should only be considered by women with permanent birth control in mind. Dr. Huster was one of the earliest adopters of Essure in the greater Kansas City area and has been active in training other physicians in this new technology. Dr. Huster has authored an article featured in Bariatric Times about Essure.
Thermachoice endometrial ablation can mean the permanent end to those heavy menstrual periods. As with Essure, Thermachoice is performed on an outpatient basis in our office or in a hospital setting. An inflatable device is placed into the uterine cavity via the cervix. The balloon device is then filled with hot water and therapy ensues for eight minutes. This heated balloon destroys most of the uterine lining (endometrium) ensuring much lighter, shorter menses. Complete cessation of menses may even sometimes be produced. Any woman considering Thermachoice should not consider further childbearing. Dr. Huster is a member of the active medical staff of Liberty Hospital. We participate with most major health plans.
Gardasil, the only cervical cancer vaccine for girls and young women ages 9 to 26 is now available in our office. Gardasil is given as 3 injections over 6 months. It offers protection against four common disease-causing strains of the Human Papillomavirus (HPV). HPV Types 16 and 18 cause 70% of cervical cancer cases, and HPV Types 6 and 11 cause 90% of genital wart cases. Gardasil may not fully protect everyone and does not prevent all types of cervical cancer, so it is important to continue regular cervical cancer screenings. Gardasil will not treat cervical cancer and genital warts and will not protect against diseases caused by other HPV types.